Reply to "breakpoints and drug exposure are inevitably closely linked"

Antimicrob Agents Chemother. 2015 Feb;59(2):1385. doi: 10.1128/AAC.04688-14.

Authors

Tawanda Gumbo¹, Jotam G Pasipanodya¹, Peter Wash², André Burger², Helen McIlleron³

Affiliations

¹ Baylor Research Institute, Dallas, Texas, USA.
² Brewelskloof Hospital, Worcester, South Africa.
³ Division of Pharmacology, Department of Medicine, University of Cape Town, Observatory, South Africa Helen.McIlleron@uct.ac.za.

No abstract available

Publication types

Comment

MeSH terms

Antitubercular Agents / therapeutic use*
Female
Humans
Isoniazid / therapeutic use*
Male
Rifampin / therapeutic use*
Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

Antitubercular Agents
Isoniazid
Rifampin